Bruce Zimmermann

India likely to allow smaller gap between AstraZeneca COVID vaccine doses sold privately - sources

India is likely to allow a smaller gap between AstraZeneca COVID-19 vaccine doses for inoculations being carried out privately, in line with a court order, two sources told Reuters. Private hospitals and clinics will give their paying patients the option to receive their second dose of the vaccine four weeks after the first, down from between 12 and 16 weeks currently, they said. Earlier this month, the high court in the southern state of Kerala ordered changes https://www.reuters.com/business/healthcare-pharmaceuticals/indian-court-backs-shorter-dose-gap-those-paying-astrazeneca-vaccine-2021-09-07 in the health ministry's vaccine-booking platform to give people paying for vaccination this choice, which is already being offered to those flying abroad.

• 
  Pfizer: COVID-19 vaccine is safe and effective in kids

  WFTS-Tampa
• 
  When Can Kids Get The COVID-19 Vaccine — And What Should Parents Know Now?

  HuffPost Life

Chinese builder in debt jam says it will make bond payment

A Chinese real estate developer that is struggling to avoid defaulting on billions of dollars of debt reassured jittery global markets at least briefly Wednesday by announcing it will make an interest payment due this week. The Chinese government, meanwhile, kept investors guessing about whether it might intervene. Evergrande Group’s struggle to comply with financial limits regulators imposed to curb rising debt levels has prompted fears a default might cause global shockwaves.

• 
  China Evergrande's rising default risks shift focus to possible Beijing rescue

  Reuters
• 
  Evergrande: Crisis-hit firm strikes China debt deal

  BBC

Integer to Construct New Innovation and Manufacturing Facility in Galway, Ireland

Expansion to Significantly Increase Integer’s Presence and Capabilities in Galway; Signifies Continued Growth and Commitment to Integer’s CustomersPLANO, Texas, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, today announced it will further expand its presence in Galway, Ireland, with the construction of a new Medical Device Innovation and Manufacturing facility in the Parkmore East area of Galway. This new faci